Investor Relations Home  |   News  |   Events & Webcasts  |   SEC Filings & Reports  |   Stock Info  |   Analyst Coverage  |   Fundamentals  |   Earnings Estimates  |   FAQs  |   Information Request  |   Financial Tearsheet  |   Corporate Governance


Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, ARRY-520, for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis).

Array BioPharma
Fact Sheet

Array BioPharma
2013 Annual Report

Receive E-mail AlertsE-mail Alerts
Recent NewsMore >>
03/03/14Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific MeetingPrinter Friendly Version
02/18/14Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare ConferencesPrinter Friendly Version
02/06/14Array BioPharma To Present At The Leerink Swann Global Healthcare ConferencePrinter Friendly Version
02/04/14Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Primary IR Contacts
Michael Carruthers
Chief Financial Officer
Phone: (303) 381-6663

Tricia Haugeto
Director, Corporate Communications and Investor Relations
Phone: (303) 386-1193

Transfer Agent
American Stock Transfer and Trust Company
59 Maiden Lane
Plaza Level
New York, NY 10038
Phone: (800) 937-5449
Fax: (718) 236-4588

Gross Hartman LLC
1877 Broadway, Suite 601
Boulder, CO 80302
Phone: (303) 926-4823

707 Seventeenth Street, Suite 2700
Denver, CO 80202
Phone: (303) 295-5572

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

  Printer friendly version

Stock Quote
ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.05 (1.30%)
Data as of 04/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000ARRY